Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Drug Concentration Analysis System Market CAGR Outlook And Future Development
The market size for drug concentration analysis systems has shown substantial growth in recent years. This market is expected to increase from $2.46 billion in 2025 to $2.65 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.0%. Historically, this expansion has been driven by factors such as the increasing prevalence of chronic diseases, rising healthcare expenditure, the growth in pharmaceutical research, an escalating demand for therapeutic drug monitoring, and more stringent regulatory quality control requirements.
The drug concentration analysis system market is projected to experience substantial growth over the coming years. By 2030, this market is anticipated to reach $3.57 billion, exhibiting a compound annual growth rate (CAGR) of 7.7%. Several factors contribute to this projected expansion, including heightened investments in healthcare infrastructure, a rising need for accurate drug monitoring, the expansion of pharmaceutical and biotechnology industries, the increasing integration of personalized medicine, and greater spending on pharmaceutical research and development. Key trends shaping the market during this period encompass advancements in analytical instrument technology, the emergence of point-of-care drug concentration systems, the incorporation of automation and high-throughput testing, the utilization of sophisticated bioanalytics techniques, and an increased emphasis on regulatory adherence and quality assurance.
Get A Free Sample Report With In-Depth Market Insights:
Drug Concentration Analysis System Market Industry Drivers: What’s Behind The Revenue Growth?
The increasing need for personalized medicine is anticipated to drive the expansion of the drug concentration analysis system market in the future. Personalized medicine represents a healthcare strategy focused on customizing treatments for individual patients, considering their genetic makeup, environmental influences, and lifestyle habits, thereby optimizing results and enhancing overall patient care. The escalating demand for personalized medicine stems from breakthroughs in genomic technologies, allowing for the accurate detection of genetic differences and the development of customized therapies for individuals. Drug concentration analysis systems contribute to personalized medicine by precisely quantifying drug levels within each patient, facilitating customized dosages and improved treatment plans. These systems enhance therapeutic results through the reduction of adverse effects and by guaranteeing that every patient gets the most efficacious and secure medication approach. An illustrative example is that in February 2024, the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, marking a considerable rise from the 12 approved in 2022, as reported by the Personalized Medicine Coalition (PMC), a US-based nonprofit organization. Consequently, the heightened demand for personalized medicine is fueling the expansion of the drug concentration analysis system market.
Drug Concentration Analysis System Market Segment Trends And Revenue Contributors
The drug concentration analysis system market covered in this report is segmented –
1) By Product Type: Liquid Chromatography Systems, Mass Spectrometry Systems, Spectrophotometry Systems, Immunoassays
2) By Sample Type: Blood Or Plasma Or Serum, Urine, Tissue Samples, Saliva, Cell Culture And Bioprocess Samples, Cerebrospinal Fluid (CSF), Other Biological Or Chemical Matrices
3) By Distribution Channel: Online Distribution, Offline Distribution, Direct Sales, Third Party Distributors, Retail Outlets
4) By Application: Therapeutic Drug Monitoring, Pharmaceutical Research And Development, Clinical Trials, Bioavailability Or Bioequivalence
5) By End-User: Hospitals And Clinics, Pharmaceutical Companies, Contract Research Organizations (CROs), Academic And Research Institutions, Homecare Settings
Subsegments:
1) By Liquid Chromatography Systems: High Performance Liquid Chromatography, Ultra High Performance Liquid Chromatography, Fast Protein Liquid Chromatography, Ion Exchange Liquid Chromatography, Size Exclusion Liquid Chromatography
2) By Mass Spectrometry Systems: Quadrupole Mass Spectrometry, Time Of Flight Mass Spectrometry, Ion Trap Mass Spectrometry, Fourier Transform Ion Cyclotron Resonance Mass Spectrometry, Orbitrap Mass Spectrometry
3) By Spectrophotometry Systems: Ultraviolet Visible Spectrophotometry, Infrared Spectrophotometry, Fluorescence Spectrophotometry, Atomic Absorption Spectrophotometry, Raman Spectrophotometry
4) By Immunoassays: Enzyme Linked Immunosorbent Assay, Radioimmunoassay, Chemiluminescent Immunoassay, Fluoroimmunoassay, Lateral Flow Immunoassay
#Drug Concentration Analysis System Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the drug concentration analysis system market are concentrating on developing advanced products, such as rapid on-site testing platforms. This effort aims to boost treatment optimization, enhance personalized care, and reduce the time and costs typically associated with traditional laboratory testing. Rapid on-site testing platforms are sophisticated diagnostic systems that allow for immediate, quantitative measurement of drug levels within a clinical environment. For example, in October 2023, ProciseDx Inc., a US-based in vitro diagnostics company, secured de novo FDA clearance for its therapeutic drug monitoring (TDM) tests for adalimumab (Humira and biosimilar Amgevita) and infliximab (Remicade and biosimilars Inflectra and Renflexis). These assays, named Procise ADL and Procise IFX, employ time-resolved fluorescence resonance energy transfer immunoassay technology to quantify drug concentrations in serum, delivering results in approximately five minutes. This capability facilitates near-immediate clinical decisions during patient visits. The introduction of these products signifies a major shift toward point-of-care drug concentration analysis systems, which merge quantitative precision with operational simplicity, thereby supporting personalized dosing strategies for patients with conditions like inflammatory bowel disease.
Drug Concentration Analysis System Market Top Companies Driving Competitive Growth
Major companies operating in the drug concentration analysis system market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Siemens Healthineers AG, Danaher Corporation, Agilent Technologies Inc., BioMérieux Inc., Sartorius AG, Shimadzu Corporation, PerkinElmer Inc., Bruker Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Tecan Group Ltd., Randox Laboratories Ltd., Analytik Jena GmbH & Co. KG, KNAUER Wissenschaftliche Geräte GmbH, Chromsystems Instruments & Chemicals GmbH, American Laboratory Products Company Ltd.
View The Full Drug Concentration Analysis System Market Report:
Drug Concentration Analysis System Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the drug concentration analysis system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug concentration analysis system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model